Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
Jump to:
| Preferred Name | Diazoxide | |
| Synonyms |
|
|
| Definitions |
A benzothiadiazine derivate with antihypertensive and hyperglycemic activities. Diazoxide increases membrane permeability to potassium ions in vascular smooth muscle, thereby stabilizing the membrane action potential and preventing vascular smooth muscle contraction; this results in peripheral vasodilatation and decreases in peripheral vascular resistance. This agent also inhibits insulin release by interacting with ATP-sensitive potassium channels of pancreatic islet beta-cells. |
|
| ID |
http://purl.obolibrary.org/obo/NCIT_C428 |
|
| Accepted_Therapeutic_Use_For |
Malignant Hypertension
|
|
| CAS_Registry |
364-98-7
|
|
| CHEBI_ID |
CHEBI:4495
|
|
| Chemical_Formula |
C8H7ClN2O2S
|
|
| code |
C428
|
|
| Contributing_Source |
FDA
|
|
| definition |
A benzothiadiazine derivate with antihypertensive and hyperglycemic activities. Diazoxide increases membrane permeability to potassium ions in vascular smooth muscle, thereby stabilizing the membrane action potential and preventing vascular smooth muscle contraction; this results in peripheral vasodilatation and decreases in peripheral vascular resistance. This agent also inhibits insulin release by interacting with ATP-sensitive potassium channels of pancreatic islet beta-cells.
|
|
| FDA_UNII_Code |
O5CB12L4FN
|
|
| in_subset | ||
| label |
Diazoxide
|
|
| Legacy Concept Name |
Diazoxide
|
|
| NCI_Drug_Dictionary_ID |
39290
|
|
| NSC Number |
64198 76130
|
|
| PDQ_Closed_Trial_Search_ID |
39290
|
|
| PDQ_Open_Trial_Search_ID |
39290
|
|
| Preferred_Name |
Diazoxide
|
|
| prefixIRI |
NCIT:C428
|
|
| prefLabel |
Diazoxide
|
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance
|
|
| UMLS_CUI |
C0012022
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping